Rapamycin (Sirolimus): A Comprehensive Guide
Discover the multifaceted nature of Rapamycin (Sirolimus), from its intricate chemical properties to its life-changing medical applications and cutting-edge research potential.
Get a Quote & SampleProduct Core Value
Rapamycin
Rapamycin, also known as Sirolimus (CAS 53123-88-9), is a potent macrolide compound renowned for its immunosuppressive and antiproliferative properties. Its primary mechanism involves inhibiting the mammalian target of rapamycin (mTOR) pathway, a critical regulator of cell growth, proliferation, and survival. This action underpins its extensive use in preventing organ transplant rejection and its emerging roles in cancer therapy and understanding cellular processes like autophagy.
- Leveraging Rapamycin's immunosuppressant properties is crucial for preventing organ transplant rejection, a key application of this compound.
- Exploring Rapamycin's mechanism of action as an mTOR inhibitor is vital for understanding its therapeutic effects in various disease contexts.
- Understanding Sirolimus solubility in DMSO is important for researchers preparing experimental solutions.
- Investigating Rapamycin's broad research applications, from cancer treatment to longevity studies, highlights its scientific significance.
Key Advantages
Targeted mTOR Inhibition
Rapamycin's precise inhibition of the mTOR pathway makes it a valuable tool for modulating cell growth and proliferation, impacting various biological processes and disease states.
Broad Therapeutic Potential
Beyond transplant medicine, Rapamycin's antiproliferative effects are being investigated for cancer treatment, autoimmune diseases, and even as a potential factor in longevity research, expanding its impact.
Research Versatility
As a well-characterized compound, Rapamycin serves as a critical reagent in numerous biological research studies, aiding in the understanding of fundamental cellular mechanisms like autophagy.
Key Applications
Organ Transplant Support
Sirolimus is extensively used to prevent the body from rejecting transplanted organs, ensuring graft survival and improving patient outcomes.
Lymphangioleiomyomatosis Treatment
This rare lung disease affecting women of childbearing age is treated with Rapamycin, offering a therapeutic option where few previously existed.
Cardiovascular Stent Coatings
The antiproliferative action of Rapamycin is utilized in drug-eluting stents to prevent restenosis in coronary arteries following angioplasty.
Advanced Biological Research
Researchers utilize Rapamycin extensively to study cellular pathways, including autophagy, cell cycle regulation, and responses to various stimuli.